BOSTON & SAN DIEGO--(BUSINESS WIRE)--Rapport Therapeutics, Inc., a clinical-stage biotechnology company leveraging the science of receptor-associated proteins (RAPs) to advance precision ...

Please provide your email address to receive an email when new articles are posted on . A clinical-stage biotechnology company announced that it has raised $150 million in funding to advance its ...

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Ceretype Neuromedicine, a pioneer in the practical application and integration of functional MRI (fMRI), announced today that it has closed its second round of seed ...

University of Florida Health in Gainesville will open the UF Health Heart & Vascular Hospital and the UF Health Neuromedicine Hospital next month. In a news release, UF Health said the $415 million ...

The theory of neuromedicine involves an understanding of humans as having three components: mind, body and neuroenergy. Its techniques allow the medical practitioner to stimulate the body to heal ...

Neuromedicine services have launched at Highland Hospital in Rochester, N.Y., with the opening of a new unit that also expands the hospital’s joint center, according to a hospital news release. The ...

Rapport Therapeutics Inc. raised $150 million in a series B round, less than six months after unveiling its $100 million series A investment. It’s further evidence that its distinctive precision ...

Today we officially welcome patients into the new UF Health Heart & Vascular Hospital and the UF Health Neuromedicine Hospital. This historic milestone for the University of Florida and UF Health ...

Rochester, N.Y. (WHAM) - A new first-of-its-kind facility is opening in the Rochester area for people on the autism spectrum. UR Medicine held a grand opening Wednesday for its Neuromedicine & ...

Article ‘Count’ and ‘Share’ for Ceretype Neuromedicine based on listed parameters only. According to the parameters selected above, there are no articles from Ceretype Neuromedicine from 1 December ...

- Raymond Kelleher, M.D., Ph.D., of lead investor Cormorant Asset Management, and James Healy, M.D., Ph.D., of Sofinnova Investments, join Board of Directors BOSTON ...